Alemtuzumab is currently not available.
Our suppliers are constantly updating their product inventory and availability status. If you would like us to notify you when Alemtuzumab becomes available, please fill out the form below.
*We value your privacy! We will never give, lease, sell or otherwise disclose your personal information. Period!
Information about SaveRxCanada.to
List of countries where we can ship Alemtuzumab:
Latest news releases on Alemtuzumab:
Alemtuzumab is a drug used in the treatment of chronic lymphocytic leukemia (CLL), cutaneous T-cell lymphoma (CTCL) and T-cell lymphoma under the trade names Campath, ...
L'alemtuzumab (commercialisé sous les noms de Campath, MabCampath, Campath-1H et plus récemment de Lemtrada) est un anticorps monoclonal IgG1 kappa humanisé ...
L'alemtuzumab è un anticorpo monoclonale umanizzato utilizzato contro la leucemia linfatica cronica. Per il suo meccanismo di azione favorisce la riuscita della lisi ...
Physician reviewed alemtuzumab patient information - includes alemtuzumab description, dosage and directions.
Learn about Campath (Alemtuzumab) may treat, uses, dosage, side effects, drug interactions, warnings, patient labeling, reviews, and related medications.
Lemtrada can reduce relapse rates and slow disease progression in patients with relapsing-remitting multiple sclerosis, but its use carries high risks.
Professional guide for Alemtuzumab. Includes: pharmacology, pharmacokinetics, contraindications, interactions, adverse reactions and more.
A Study to Evaluate Efficacy, Safety, and Tolerability of Alemtuzumab in Pediatric Patients With RRMS With Disease Activity on Prior DMT (LemKids)
Return to Table of Contents. Campath ® (ALEMTUZUMAB) DESCRIPTION. Campath ® (Alemtuzumab) is a recombinant DNA-derived humanized monoclonal antibody (Campath-1H ...
Alemtuzumab (Lemtrada™) 12 milligram (mg) per day intravenous (IV) infusion on 5 consecutive days at Month 0, followed by alemtuzumab 12 mg per day IV infusion on 3 ...